Verona Pharma plc (NASDAQ:VRNA) Q4 2024 Earnings Call Transcript February 27, 2025
Verona Pharma plc misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.23.
Operator: Good morning, ladies and gentlemen. Welcome to the Verona Pharma fourth quarter and full year 2024 financial results and conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you...
